LHC Group, Inc. (NASDAQ:LHCG) has received a consensus rating of “Buy” from the twelve analysts that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $124.78.
A number of brokerages recently weighed in on LHCG. Jefferies Financial Group lifted their price objective on shares of LHC Group from $125.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, May 9th. BidaskClub raised shares of LHC Group from a “buy” rating to a “strong-buy” rating in a research report on Friday. Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $130.00 target price on the stock in a research report on Thursday, June 27th. UBS Group set a $133.00 target price on shares of LHC Group and gave the company a “buy” rating in a research report on Friday, May 10th. Finally, Barclays reissued a “hold” rating on shares of LHC Group in a research report on Sunday, May 12th.
In other news, Director Ronald T. Nixon sold 12,000 shares of LHC Group stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $117.20, for a total value of $1,406,400.00. Following the transaction, the director now owns 29,100 shares of the company’s stock, valued at approximately $3,410,520. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Donald Dwayne Stelly sold 448 shares of LHC Group stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $120.00, for a total transaction of $53,760.00. Following the completion of the transaction, the chief operating officer now directly owns 91,252 shares in the company, valued at approximately $10,950,240. The disclosure for this sale can be found here. Insiders have sold a total of 46,269 shares of company stock worth $5,314,613 in the last three months. Insiders own 5.20% of the company’s stock.
Shares of LHC Group stock traded up $1.50 during trading on Tuesday, hitting $121.73. The stock had a trading volume of 133,220 shares, compared to its average volume of 245,443. The company has a fifty day simple moving average of $121.28. The firm has a market capitalization of $3.89 billion, a PE ratio of 34.29, a PEG ratio of 2.10 and a beta of 0.84. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 1.57. LHC Group has a 12 month low of $80.84 and a 12 month high of $129.37.
LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.08. The firm had revenue of $502.59 million during the quarter, compared to analyst estimates of $511.16 million. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. Analysts forecast that LHC Group will post 4.3 earnings per share for the current year.
About LHC Group
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Further Reading: What are gap-up stocks?
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.